BiomX Inc.
PHGE
$0.5501
$0.00330.60%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 14.21M | 14.48M | 13.91M | 11.38M | 10.29M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.23M | 36.39M | 34.68M | 31.44M | 28.70M |
| Operating Income | -34.23M | -36.39M | -34.68M | -31.44M | -28.70M |
| Income Before Tax | -18.56M | -8.05M | -17.71M | -8.69M | -26.23M |
| Income Tax Expenses | 6.00K | 9.00K | 13.00K | 11.00K | 19.00K |
| Earnings from Continuing Operations | -18.57 | -8.06 | -17.73 | -8.71 | -26.25 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.57M | -8.06M | -17.73M | -8.71M | -26.25M |
| EBIT | -34.23M | -36.39M | -34.68M | -31.44M | -28.70M |
| EBITDA | -32.46M | -34.58M | -32.87M | -30.34M | -27.71M |
| EPS Basic | -1.01 | -0.68 | -2.57 | -2.67 | -4.29 |
| Normalized Basic EPS | -0.15 | 0.39 | -1.07 | -1.42 | -2.63 |
| EPS Diluted | -1.10 | -1.60 | -3.48 | -3.50 | -5.12 |
| Normalized Diluted EPS | -0.15 | 0.24 | -1.21 | -1.56 | -2.77 |
| Average Basic Shares Outstanding | 89.02M | 64.69M | 47.82M | 35.65M | 25.34M |
| Average Diluted Shares Outstanding | 89.02M | 68.46M | 51.59M | 39.42M | 29.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |